This inventor holds 1 USPTO granted patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Arye Shteyer: Innovator in Osteogenic Growth Polypeptides
Introduction
Arye Shteyer is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of biochemistry, particularly in the area of osteogenic growth polypeptides. His work focuses on the stimulation of bone formation and hemopoietic reconstruction, which has important implications for medical science.
Latest Patents
Arye Shteyer holds a patent for "Osteogenic growth polypeptides identified from regenerating bone marrow." This biochemically pure polypeptide, termed osteogenic growth polypeptide (OGP), exhibits stimulatory effects on osteoblastic cells, promoting in vivo bone formation and hemopoietic reconstruction. The amino acid sequence of OGP is derived from regenerating bone marrow, highlighting its potential in therapeutic applications.
Career Highlights
Shteyer is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in advancing our understanding of bone regeneration and the biochemical processes involved. His research has garnered attention for its innovative approach to addressing challenges in bone health.
Collaborations
Some of Arye Shteyer's notable collaborators include Gideon A Rodan and John W Jacobs. Their combined expertise has contributed to the successful development of his research and patents.
Conclusion
Arye Shteyer's contributions to the field of biochemistry, particularly through his patent on osteogenic growth polypeptides, demonstrate his commitment to advancing medical science. His work continues to inspire further research and innovation in bone health and regeneration.